BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15595584)

  • 1. An investigation of non-depolarizing muscle relaxants on embryonic development in cultured rat embryos.
    Karabulut AK; Reisli R; Uysal II; Celik JB; Ziylan T
    Eur J Anaesthesiol; 2004 Sep; 21(9):715-24. PubMed ID: 15595584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental toxicity of nondepolarizing muscle relaxants in cultured rat embryos.
    Fujinaga M; Baden JM; Mazze RI
    Anesthesiology; 1992 Jun; 76(6):999-1003. PubMed ID: 1350890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle Relaxants as a Risk Factor for Vis-à-tergo During Penetrating Keratoplasty: A Prospective Interventional Study.
    Fiorentzis M; Morinello E; Viestenz A; Zuche H; Seitz B; Viestenz A
    Adv Ther; 2017 Dec; 34(12):2674-2679. PubMed ID: 29101713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of developmental toxicity and teratogenicity of macrolide antibiotics in cultured rat embryos.
    Karabulut AK; Uysal II; Acar H; Fazliogullari Z
    Anat Histol Embryol; 2008 Oct; 37(5):369-75. PubMed ID: 18537945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New muscle relaxants. Update on mivacurium, rocuronium and cis-atracurium].
    Fuchs-Buder T
    Anaesthesist; 1997 Apr; 46(4):350-9. PubMed ID: 9229990
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of intubating conditions at the first minute with suxamethonium, rocuronium and different priming techniques of rocuronium.
    Ortiz-Gómez JR; Carrascosa F; Pérez-Cajaraville JJ; Percaz-Bados JA; Añez C
    Eur J Anaesthesiol; 2005 Apr; 22(4):263-8. PubMed ID: 15892403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
    Kansanaho M; Olkkola KT
    Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of non-depolarizing muscle relaxants on the duration of mivacurium].
    Steinberg D; Chalita J
    Acta Cient Venez; 2001; 52(1):40-5. PubMed ID: 11510427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer neuromuscular blocking agents.
    Bevan DR
    Pharmacol Toxicol; 1994 Jan; 74(1):3-9. PubMed ID: 8159634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weal and flare responses to intradermal rocuronium and cisatracurium in humans.
    Levy JH; Gottge M; Szlam F; Zaffer R; McCall C
    Br J Anaesth; 2000 Dec; 85(6):844-9. PubMed ID: 11732517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Effect of Non-Depolarising Muscle Relaxants on Ocular Pulse Amplitude and Intraocular Pressure].
    Zuche H; Morinello E; Viestenz A; Fiorentzis MF; Volk T; Seitz B; Viestenz A
    Klin Monbl Augenheilkd; 2015 Dec; 232(12):1397-1401. PubMed ID: 25997093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New muscle relaxants].
    Diefenbach C; Buzello W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):2-8. PubMed ID: 8868525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of recurarization during retransfusion of autologous blood withdrawn after injection of muscle relaxants: a comparison of rocuronium and mivacurium.
    Rohling RG; Rentsch KM; Beck-Schimmer B; Fuchs-Buder T
    J Clin Anesth; 2003 Mar; 15(2):85-90. PubMed ID: 12719045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.